Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
CC transcript
Director departure

CASI Pharmaceuticals, Inc (DE) (CASI) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/09/2022 4 Zukiwski Alexander A (EVP and Chief Medical Officer) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Granted 3,000 options to buy @ $0
09/08/2022 4 Huang James (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Bought 19,162 shares @ $3.8932, valued at $74.6k
Bought 3,111 shares @ $3.9965, valued at $12.4k
Bought 33,300 shares @ $4.2831, valued at $142.6k
09/02/2022 4 Huang James (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Bought 24,975 shares @ $3.745, valued at $93.5k
Bought 11,821 shares @ $3.7229, valued at $44k
Bought 400 shares @ $3.7413, valued at $1.5k
08/26/2022 4 Huang James (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Bought 5,000 shares @ $3.7502, valued at $18.8k
Bought 39,527 shares @ $3.7488, valued at $148.2k
08/23/2022 4 Huang James (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Bought 171,116 shares @ $3.2694, valued at $559.4k
Bought 23,105 shares @ $3.4641, valued at $80k
Bought 40,000 shares @ $3.4998, valued at $140k
06/17/2022 4 He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Bought 36,058 shares @ $2.97, valued at $107.1k
Bought 2,096 shares @ $3.06, valued at $6.4k
Bought 50,000 shares @ $3.18, valued at $159k
05/26/2022 4 Zhou Quan (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Granted 380,645 options to buy @ $0.4664, valued at $177.5k
05/26/2022 4 Huang James (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Granted 397,419 options to buy @ $0.4664, valued at $185.4k
05/26/2022 4 Wu Yue Alexander (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Granted 388,387 options to buy @ $0.4664, valued at $181.1k
05/26/2022 4 Salisbury Franklin Cary jr (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Granted 388,387 options to buy @ $0.4664, valued at $181.1k
05/26/2022 4 SHROTRIYA RAJESH C MD (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Granted 345,806 options to buy @ $0.4664, valued at $161.3k
12/06/2021 4 Zukiwski Alexander A (Chief Medical Officer) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Granted 500,000 options to buy @ $0.87, valued at $435k
11/19/2021 4 He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Bought 200,000 shares @ $0.99, valued at $198k
Bought 200,000 shares @ $0.98, valued at $196k
08/20/2021 4 He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Bought 300,000 shares @ $1.29, valued at $387k
Bought 180,000 shares @ $1.26, valued at $226.8k
07/26/2021 4 Zhang Larry (President) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Granted 800,000 options to buy @ $1.28, valued at $1M
06/16/2021 4 Zhou Quan (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Granted 108,257 options to buy @ $1.65, valued at $178.6k
06/16/2021 4 Wu Yue Alexander (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Granted 110,459 options to buy @ $1.65, valued at $182.3k
06/16/2021 4 SHROTRIYA RAJESH C MD (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Granted 98 options to buy @ $1.65, valued at $162.3
06/16/2021 4 Salisbury Franklin Cary jr (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Granted 110,459 options to buy @ $1.65, valued at $182.3k
06/16/2021 4 Huang James (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Granted 113,028 options to buy @ $1.65, valued at $186.5k
06/16/2021 4 He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Granted 4,000,000 options to buy @ $1.73, valued at $6.9M
03/30/2021 4 He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Bought 3,000,000 shares @ $2.05, valued at $6.2M
12/23/2020 4 He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Gifted 380,000 shares @ $0
12/18/2020 4 Xu Weihao (CFO) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Bought 2,000 shares @ $2.44, valued at $4.9k
Bought 1,721 shares @ $2.64, valued at $4.5k
Bought 2,279 shares @ $2.63, valued at $6k
Granted 800,000 options to buy @ $2.61, valued at $2.1M
12/18/2020 3 Xu Weihao (CFO) has filed a Form 3 on CASI Pharmaceuticals, Inc.
11/24/2020 4 He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Bought 127,471 shares @ $2.12, valued at $270.2k
Bought 100,000 shares @ $2.18, valued at $218k
07/24/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/24/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/18/2020 4 Zhou Quan (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Granted 67,429 options to buy @ $2.63, valued at $177.3k
06/18/2020 4 Huang James (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Granted 70,400 options to buy @ $2.63, valued at $185.2k
06/18/2020 4 Wu Yue Alexander (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Granted 68,800 options to buy @ $2.63, valued at $180.9k
06/18/2020 4 Salisbury Franklin Cary jr (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Granted 68,800 options to buy @ $2.63, valued at $180.9k
06/18/2020 4 SHROTRIYA RAJESH C MD (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Granted 61,257 options to buy @ $2.63, valued at $161.1k
05/21/2020 4 He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.
Txns: Bought 29,801 shares @ $2.03, valued at $60.5k
Bought 56,464 shares @ $2.37, valued at $133.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy